Correction: Durán-Ferrer et al. Clinical, Virological and Immunological Responses After Experimental Infection with African Horse Sickness Virus Serotype 9 in Immunologically Naïve and Vaccinated Horses. <i>Viruses</i> 2022, <i>14</i>, 1545. [PDF]
Durán-Ferrer M +10 more
europepmc +1 more source
Correction: Villalba et al. Development and Validation of Three Triplex Real-Time RT-PCR Assays for Typing African Horse Sickness Virus: Utility for Disease Control and Other Laboratory Applications. <i>Viruses</i> 2024, <i>16</i>, 470. [PDF]
Villalba R +6 more
europepmc +1 more source
Pneumococcal serotype distribution and diagnostic yield of serotype-specific urinary antigen detection in adults with CAP in Switzerland, 2016-2021: a prospective cohort study. [PDF]
Etienne S +7 more
europepmc +1 more source
Early warning of serotype replacement, spatial risk redistribution, and shifting clinical phenotypes: Insights from the 2023-2025 dengue outbreak in Meta, Colombia. [PDF]
Montilla Rodríguez LM +9 more
europepmc +1 more source
Genomic epidemiology of <i>Streptococcus pneumoniae</i> reveals globally disseminated lineages and capsular switching in the Arabian Gulf region. [PDF]
Senok A +15 more
europepmc +1 more source
Overall and serotype-specific dengue virus transmission intensity in Mexico, 2016-2023: A modelling study of case-notification data. [PDF]
Simmons OS +4 more
europepmc +1 more source
Systematic Review and Meta-analysis of Group B Streptococcus Rectovaginal Colonization Rates and Serotype Distribution among Pregnant Women, Asia-Pacific Region, 2014-2025. [PDF]
Toh ZQ +4 more
europepmc +1 more source
Resistance, virulence, and population genomic structure of avian pathogenic Escherichia coli from poultry airsacculitis in South Africa. [PDF]
Wang Z +3 more
europepmc +1 more source
Recommendations for Adult Pneumococcal Vaccination in Korea: 2026 Update Incorporating the 21-Valent Pneumococcal Conjugate Vaccine. [PDF]
Song JY +10 more
europepmc +1 more source
Open-label, randomised controlled, multicentre study evaluating higher valency pneumococcal vaccines (PCV15/PCV20) compared with PCV13 given in homologous schedules at 3 months and 12 months ('1+1' schedule) and 2 months, 4 months and 12 months ('2+1' schedule) in infants: protocol. [PDF]
Aslam R +19 more
europepmc +1 more source

